Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Chabot

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Clinical Pharmacokinetics|October 29, 1997
Clinical pharmacokinetics of irinotecanG G Chabot
Anticancer Research|November 1, 1994
Factors involved in clinical pharmacology variability in oncology (review)G G Chabot
Cancer Chemotherapy and Pharmacology|January 1, 1995
Limited sampling models for simultaneous estimation of the pharmacokinetics of irinotecan and its active metabolite SN-38G G Chabot
Annals of the New York Academy of Sciences|December 13, 1996
Clinical pharmacology and pharmacodynamics of irinotecan. A reviewG G Chabot
Biochemical Pharmacology|August 8, 1991
Reactivity of flavone acetic acid and its acyl glucuronideG G Chabot, A Gouyette
Leukemia Research|January 1, 1986
Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cellsG G Chabot, R L Momparler
Cancer Treatment Reports|December 1, 1984
Antileukemic activity of 5-aza-2'-deoxycytidine and cytarabine against intracerebral L1210 murine leukemiaG G Chabot, R L Momparler
Bulletin Du Cancer|January 1, 1991
[History and new development of screening and evaluation methods of anticancer drugs used in vivo and in vitro]M C Bissery, G G Chabot
Cancer Chemotherapy and Pharmacology|January 1, 1989
Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitroG G Chabot, M C Bissery, A Gouyette
Investigational New Drugs|December 1, 1987
Phase I study and pharmacokinetics of caracemide (NSC-253272) administered as a short infusionR Pazdur, G G Chabot, L H Baker
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Clinical Pharmacokinetics|October 29, 1997
Clinical pharmacokinetics of irinotecanG G Chabot
Anticancer Research|November 1, 1994
Factors involved in clinical pharmacology variability in oncology (review)G G Chabot
Cancer Chemotherapy and Pharmacology|January 1, 1995
Limited sampling models for simultaneous estimation of the pharmacokinetics of irinotecan and its active metabolite SN-38G G Chabot
Annals of the New York Academy of Sciences|December 13, 1996
Clinical pharmacology and pharmacodynamics of irinotecan. A reviewG G Chabot
Biochemical Pharmacology|August 8, 1991
Reactivity of flavone acetic acid and its acyl glucuronideG G Chabot, A Gouyette
Leukemia Research|January 1, 1986
Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cellsG G Chabot, R L Momparler
Cancer Treatment Reports|December 1, 1984
Antileukemic activity of 5-aza-2'-deoxycytidine and cytarabine against intracerebral L1210 murine leukemiaG G Chabot, R L Momparler
Bulletin Du Cancer|January 1, 1991
[History and new development of screening and evaluation methods of anticancer drugs used in vivo and in vitro]M C Bissery, G G Chabot
Cancer Chemotherapy and Pharmacology|January 1, 1989
Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitroG G Chabot, M C Bissery, A Gouyette
Investigational New Drugs|December 1, 1987
Phase I study and pharmacokinetics of caracemide (NSC-253272) administered as a short infusionR Pazdur, G G Chabot, L H Baker
Pageof 6